Patients with neurological conditions will be among those in the next priority group for COVID-19 vaccine when phase 1b of the rollout commences on 22 March. With phase 1a having targeted frontline COVID-19 workers to receive Pfizer’s vaccine (‘Comirnaty’) through clinic hubs, the next phase, 1b, is planned to deliver up to 15 million doses ...
Neurology patients to access COVID-19 vaccine from 22 March
By Michael Woodhead
10 Mar 2021